Please see below a statement from CSL Seqirus on how Pharmacists can access stock of Dukoral for the prevention of cholera.
Healthcare professionals may be aware that Dukoral® (oral inactivated cholera vaccine) has been in short-supply. CSL Seqirus’ priority is to ensure continuing access to Dukoral for patients requiring immunisation for the prevention of cholera.
CSL Seqirus has a batch of Dukoral twin packs available which expire on 31 March 2023. We are requesting wholesalers to hold a small volume of this short-dated stock on hand, to supply pharmacies or clinics on request. Pharmacies and clinics should contact their wholesalers directly via email or phone to order this stock as the wholesaler’s ordering portal may not reflect availability of this stock. Healthcare professionals with a CSL Seqirus account can contact our Customer Service on 1800 008 275 or customer.service.au@seqirus.com.
CSL Seqirus will provide a credit for any short-dated Dukoral stock of this batch that has been purchased and remains unused at the moment of expiry. Customers who purchase via a wholesaler should claim their credit for any remaining stock purchased during this period via their wholesaler.
At this stage, we anticipate that new Dukoral stock will become available from the manufacturer early in the second quarter of 2023.
Text by: CSL Seqirus
